Addressing Vaccine Acceptance in Carceral Settings
This study aims to improve COVID-19 vaccine acceptance among people in correctional facilities in Pennsylvania. Researchers will test different behavioral interventions chosen by the ADVANCE Steering Committee. These interventions will be quickly put into practice and tested one at a time at different levels: for patients, providers, practices, and prisons. The main goal is to see how many people accept the COVID-19 vaccine up to 12 weeks after an intervention. Anyone aged 18 or older who is incarcerated in the Pennsylvania Department of Corrections can be included in the study. The study is currently unclear on its recruitment status.
- Study design
- This interventional study plans to include 37,122 participants. It uses a rapid cycle, cluster randomized trial design to test interventions.
- What's involved
- Not specified in the trial record.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for COVID-19 vaccine acceptance rates for up to 12 weeks after an intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Addressing Vaccine Acceptance in Carceral Settings Through Community Engagement
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Lisa B Puglisi, MD · PRINCIPAL_INVESTIGATOR · Yale University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- COVID-19 vaccine acceptance rateup to 12 weeks post intervention
COVID-19 vaccine acceptance rate amongst incarcerated people and correctional staff assessed as the number of participants that receive a COVID-19 vaccine dose or complete the COVID-19 vaccine series by electronic health record (EHR) or self report. This will apply to anyone not fully up-to-date with the full immunization series, which is defined as inclusive of boosters.